Trial Profile
A large clinical outcomes trial investigating Jardiance (empagliflozin) tablets for the treatment of people with chronic kidney disease
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 16 Jun 2017 New trial record